LON:DOCS Dr. Martens (DOCS) Share Price, News & Analysis GBX 66.20 -0.05 (-0.07%) As of 02/21/2025 12:45 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsDividendEarningsHeadlinesInsider Trades About Dr. Martens Stock (LON:DOCS) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Dr. Martens alerts:Sign Up Key Stats Today's Range 65.40▼ 67.2550-Day Range 65.60▼ 76.7052-Week Range 49.32▼ 100Volume428,912 shsAverage Volume1.61 million shsMarket Capitalization£642.66 millionP/E Ratio9.38Dividend Yield4.53%Price TargetN/AConsensus RatingN/A Company OverviewDr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250 index. Dr. Martens operates across three geographic regions: EMEA, Americas and APAC. Our product segments include Originals, Fusion, Kids and Casual and a complementary range of Accessories.Read More… Receive DOCS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Dr. Martens and its competitors with MarketBeat's FREE daily newsletter. Email Address DOCS Stock News HeadlinesDr. Martens plc (LON:DOCS) Insider Acquires 207 SharesFebruary 13, 2025 | insidertrades.comDoc Martens deals: Creepers, platform boots, mules on sale, but selling out fastFebruary 16, 2025 | msn.comWatch This Robotics Demo Before March 17thJeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%... Just did a demo of what Nvidia’s CEO said will be "the first multitrillion-dollar robotics industry."February 22, 2025 | Brownstone Research (Ad)Now You Can Copy Gwen Stefani's '90s Alternative Aesthetic With Dr. Martens' Newest DropFebruary 8, 2025 | msn.comBarclays Sticks to Their Hold Rating for Dr. Martens Plc (DOCS)January 28, 2025 | markets.businessinsider.comGoldman Sachs Keeps Their Hold Rating on Dr. Martens Plc (DOCS)January 28, 2025 | markets.businessinsider.comDr Martens’ shares get a kicking after the bootmaker’s latest updateJanuary 27, 2025 | uk.finance.yahoo.comDr. Martens posts Q3 sales rise, US recovery gains tractionJanuary 27, 2025 | investing.comSee More Headlines DOCS Stock Analysis - Frequently Asked Questions How have DOCS shares performed this year? Dr. Martens' stock was trading at GBX 72.20 at the beginning of the year. Since then, DOCS stock has decreased by 8.3% and is now trading at GBX 66.20. View the best growth stocks for 2025 here. How were Dr. Martens' earnings last quarter? Dr. Martens plc (LON:DOCS) announced its earnings results on Thursday, November, 28th. The company reported ($1.30) earnings per share for the quarter. Dr. Martens had a trailing twelve-month return on equity of 18.91% and a net margin of 7.89%. How do I buy shares of Dr. Martens? Shares of DOCS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock. What other stocks do shareholders of Dr. Martens own? Based on aggregate information from My MarketBeat watchlists, some other companies that Dr. Martens investors own include boohoo group (BOO), Aston Martin Lagonda Global (AML), ASOS (ASC), Vodafone Group Public (VOD), JD Sports Fashion (JD), Legal & General Group (LGEN) and Lloyds Banking Group (LLOY). Company Calendar Last Earnings11/28/2024Today2/21/2025Ex-Dividend for 4/8 Dividend3/06/2025Dividend Payable4/08/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeLON SectorConsumer Cyclical Industry Footwear & Accessories Sub-IndustryComputer Software Current SymbolLON:DOCS CUSIPN/A CIKN/A Webwww.drmartensplc.com Phone44 12 1415 7047FaxN/AEmployees890Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)GBX 7.05 Trailing P/E Ratio9.38 Forward P/E Ratio25.65 P/E Growth6.4Net Income£68.97 million Net Margins7.89% Pretax MarginN/A Return on Equity18.91% Return on Assets8.12% Debt Debt-to-Equity Ratio127.27 Current Ratio2.85 Quick Ratio1.13 Sales & Book Value Annual Sales£874.20 million Price / Sales0.74 Cash FlowGBX 4.63 per share Price / Cash Flow14.29 Book ValueGBX 37.80 per share Price / Book1.75Miscellaneous Outstanding Shares970,763,405Free FloatN/AMarket Cap£642.66 million OptionableNot Optionable Beta0.11 20 Stocks to Sell NowMarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio?Get This Free Report This page (LON:DOCS) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr. Martens plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr. Martens With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.